Benzinga | Aug 9, 2021 06:11AM EDT

Amneal Pharmaceuticals Q2 Adj. EPS $0.25 Beats $0.19 Estimate, Sales $535.00M Beat $523.25M Estimate

Amneal Pharmaceuticals (NYSE:AMRX) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.19 by 31.58 percent. This is a 92.31 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $535.00 million which beat the analyst consensus estimate of $523.25 million by 2.25 percent. This is a 15.14 percent increase over sales of $464.66 million the same period last year.